The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes
Background: Metastatic bone cancers are a significant clinical problem because metastasis disrupts normal bone homeostasis, including calcium dysregulation. Much less is known about hypocalcemia and its clinical consequences. The study analyzed serum calcium changes in metastatic bone cancer patien...
Saved in:
Main Authors: | , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
ziauddin University
2025-01-01
|
Series: | Pakistan Journal of Medicine and Dentistry |
Subjects: | |
Online Access: | https://ojs.zu.edu.pk/pjmd/article/view/3323 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
_version_ | 1832594242633990144 |
---|---|
author | Muhammad Khizar Memon Syed Uzair Mahmood Sidra Memon Azhar Rashid Muhammad Ali Memon Shahzad Ali Jiskani |
author_facet | Muhammad Khizar Memon Syed Uzair Mahmood Sidra Memon Azhar Rashid Muhammad Ali Memon Shahzad Ali Jiskani |
author_sort | Muhammad Khizar Memon |
collection | DOAJ |
description |
Background: Metastatic bone cancers are a significant clinical problem because metastasis disrupts normal bone homeostasis, including calcium dysregulation. Much less is known about hypocalcemia and its clinical consequences. The study analyzed serum calcium changes in metastatic bone cancer patients, assessed differences across diagnoses and clinical stages, and evaluated alkaline phosphatase levels and types of bone lesions.
Method: A prospective study was conducted on 100 metastatic bone cancers using convenience sampling, at Indus Medical College Hospital, between March and April 2020. The patients were categorized based on the principle tumor type, clinical stage, and bone scan results. Serum calcium, corrected calcium, albumin, and ALP are measured and analyzed using descriptive and inferential statistics. Data analysis was done by SPSS using one-way ANOVA, t-tests, Pearson correlation, regression analysis, and Chi-square tests. A p-value of <0.05 was considered significant.
Results: The mean serum calcium was 8.5 ± 0.6 mg/dl. The corrected calcium level of the patients with breast cancer was statistically lower compared with the prostate cancer patients - 8.3 ± 0.5 mg/dl (p = 0.01) compared with 9.0 ± 0.6 mg/dl. The levels of ALP in blastic lesions were higher than in lytic ones, amounting to 600 ± 300 IU/L and 250 ± 100 IU/L, respectively. There was marked regression in the main diagnosis and ALP levels, which occurred with serum calcium being altered in breast cancer.
Conclusion: Serum calcium levels vary significantly among different types of cancers and stages, suggesting a vigilant monitoring of calcium and ALP levels in clinical practice.
|
format | Article |
id | doaj-art-cf654a6758ec4f2e90d2118fff1a7104 |
institution | Kabale University |
issn | 2313-7371 2308-2593 |
language | English |
publishDate | 2025-01-01 |
publisher | ziauddin University |
record_format | Article |
series | Pakistan Journal of Medicine and Dentistry |
spelling | doaj-art-cf654a6758ec4f2e90d2118fff1a71042025-01-19T20:18:27Zengziauddin UniversityPakistan Journal of Medicine and Dentistry2313-73712308-25932025-01-0114110.36283/ziun-pjmd14-1/002The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient OutcomesMuhammad Khizar Memon0Syed Uzair Mahmood1Sidra Memon2Azhar Rashid3Muhammad Ali Memon4Shahzad Ali Jiskani5Allegheny Health Network, United StatesShine Humanity, Karachi, Sindh, PakistanPiedmont Macon Medical Center, GeorgiaNCCI, Karachi, Pakistan.Indus Medical College, Tando Muhammad Khan, Sindh, PakistanChandka Medical College @ SMBBMU, Larkana, Sindh, Pakistan Background: Metastatic bone cancers are a significant clinical problem because metastasis disrupts normal bone homeostasis, including calcium dysregulation. Much less is known about hypocalcemia and its clinical consequences. The study analyzed serum calcium changes in metastatic bone cancer patients, assessed differences across diagnoses and clinical stages, and evaluated alkaline phosphatase levels and types of bone lesions. Method: A prospective study was conducted on 100 metastatic bone cancers using convenience sampling, at Indus Medical College Hospital, between March and April 2020. The patients were categorized based on the principle tumor type, clinical stage, and bone scan results. Serum calcium, corrected calcium, albumin, and ALP are measured and analyzed using descriptive and inferential statistics. Data analysis was done by SPSS using one-way ANOVA, t-tests, Pearson correlation, regression analysis, and Chi-square tests. A p-value of <0.05 was considered significant. Results: The mean serum calcium was 8.5 ± 0.6 mg/dl. The corrected calcium level of the patients with breast cancer was statistically lower compared with the prostate cancer patients - 8.3 ± 0.5 mg/dl (p = 0.01) compared with 9.0 ± 0.6 mg/dl. The levels of ALP in blastic lesions were higher than in lytic ones, amounting to 600 ± 300 IU/L and 250 ± 100 IU/L, respectively. There was marked regression in the main diagnosis and ALP levels, which occurred with serum calcium being altered in breast cancer. Conclusion: Serum calcium levels vary significantly among different types of cancers and stages, suggesting a vigilant monitoring of calcium and ALP levels in clinical practice. https://ojs.zu.edu.pk/pjmd/article/view/3323Metastatic Bone Cancer Serum CalciumAlkaline PhosphataseCalcium DysregulationHypocalcemia |
spellingShingle | Muhammad Khizar Memon Syed Uzair Mahmood Sidra Memon Azhar Rashid Muhammad Ali Memon Shahzad Ali Jiskani The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes Pakistan Journal of Medicine and Dentistry Metastatic Bone Cancer Serum Calcium Alkaline Phosphatase Calcium Dysregulation Hypocalcemia |
title | The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes |
title_full | The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes |
title_fullStr | The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes |
title_full_unstemmed | The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes |
title_short | The Impact of Metastatic Bone Cancers on Serum Calcium Levels: A Focused Analysis of Patient Outcomes |
title_sort | impact of metastatic bone cancers on serum calcium levels a focused analysis of patient outcomes |
topic | Metastatic Bone Cancer Serum Calcium Alkaline Phosphatase Calcium Dysregulation Hypocalcemia |
url | https://ojs.zu.edu.pk/pjmd/article/view/3323 |
work_keys_str_mv | AT muhammadkhizarmemon theimpactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes AT syeduzairmahmood theimpactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes AT sidramemon theimpactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes AT azharrashid theimpactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes AT muhammadalimemon theimpactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes AT shahzadalijiskani theimpactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes AT muhammadkhizarmemon impactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes AT syeduzairmahmood impactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes AT sidramemon impactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes AT azharrashid impactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes AT muhammadalimemon impactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes AT shahzadalijiskani impactofmetastaticbonecancersonserumcalciumlevelsafocusedanalysisofpatientoutcomes |